Search Results

62 results were found

Activity Type CME Provider Title Credit Hours Fee End Date
Reset sort order
JAMA Oncology Contemporary Management of Acute Myeloid Leukemia - A Review 1 Yes 8/8/2027
JAMA Oncology Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma - A Review 1 Yes 8/3/2025
JAMA Oncology Current Management of Desmoid Tumors - A Review 1 Yes 6/20/2027
JAMA Oncology Decentralized Clinical Trials as a New Paradigm of Trial Delivery to Improve Equity of Access 1 Yes 2/15/2027
JAMA Oncology Endometrial Cancer Classification and Management in the Molecular Subtyping Era 1 Yes 10/10/2027
JAMA Oncology Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant 1 Yes 4/22/2025
JAMA Oncology Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant 1 Yes 4/22/2025
JAMA Oncology Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease 1 Yes 4/21/2025
JAMA Oncology Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease 1 Yes 4/21/2025
JAMA Oncology Externally Controlled Studies Using Real-World Data in Patients With Hematological Cancers - A Systematic Review 1 Yes 8/29/2027
JAMA Oncology Global Association of COVID-19 Pandemic Measures With Cancer Screening - A Systematic Review and Meta-analysis 1 Yes 8/1/2025
JAMA Oncology Global Association of COVID-19 Pandemic Measures With Cancer Screening- A Systematic Review and Meta-analysis 1 Yes 8/1/2025
JAMA Oncology Hairy Kidneys and Sclerotic Bone Lesions 1 Yes 10/24/2027
JAMA Oncology Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer - A Review 1 Yes 9/12/2027
JAMA Oncology Identification of Deaths Caused by Cancer and COVID-19 in the US During March to December 2020 1 Yes 10/26/2025
JAMA Oncology Identification of Deaths Caused by Cancer and COVID-19 in the US During March to December 2020 1 Yes 10/26/2025
JAMA Oncology Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma - A Review 1 Yes 12/14/2026
JAMA Oncology Immunotherapy in the Treatment of Localized Genitourinary Cancers 1 Yes 8/10/2026
JAMA Oncology Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer 1 Yes 9/23/2025
JAMA Oncology Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer 1 Yes 9/23/2025